KAM
JAZZ icon

Krensavage Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Krensavage Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4M Hold
167,816
– – 15.36% 2
2026
Q1 		$31.7M Hold
167,816
– – 12.41% 3
2025
Q4 		$28.5M Hold
167,816
– – 10.08% 4
2025
Q3 		$22.1M Buy
167,816
+3,000
+2% +$360K 9.42% 3
2025
Q2 		$17.5M Buy
164,816
+64,113
+64% +$6.96M 9.26% 4
2025
Q1 		$12.5M Sell
100,703
-5,100
-5% -$665K 6.91% 5
2024
Q4 		$13M Sell
105,803
-4,454
-4% -$525K 7.71% 5
2024
Q3 		$12.3M Buy
110,257
+1,181
+1% +$129K 6.88% 6
2024
Q2 		$11.6M Buy
109,076
+7,925
+8% +$871K 5.35% 7
2024
Q1 		$12.2M Buy
101,151
+1,151
+1% +$141K 5.4% 7
2023
Q4 		$12.3M Buy
+100,000
New +$12.5M 4.36% 8

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Krensavage Asset Management's JAZZ Position: Q2 2026 in Review

Krensavage Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 167,816 shares worth $40.4M. The position accounts for 15.36% of the portfolio, ranked #2.

Krensavage Asset Management first reported a position in JAZZ in Q4 2023 and has held it in 11 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Krensavage Asset Management held 167,816 shares of Jazz Pharmaceuticals worth $40.4M as of Q2 2026.
  • Krensavage Asset Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 15.36% of Krensavage Asset Management's portfolio in Q2 2026, its #2 holding.
  • Krensavage Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Krensavage Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.